Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
about
The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesiclesSoluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseIdentification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor FamilySoluble low density lipoprotein receptor-related protein (LRP) circulates in human plasmaSorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells.Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis.Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulationCytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways.Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic miceProgressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes.Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor proteinIncreased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantationPolymorphisms in the tumor necrosis factor receptor genes affect the expression levels of membrane-bound type I and type II receptors.Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.Binding of cytokines to pharmaceutically prepared human immunoglobulin.On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparinTumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseasesBiopathologic features of Hodgkin's disease.TNF receptors in chronic lymphocytic leukemia.Selective ectodomain phosphorylation and regulated cleavage of beta-amyloid precursor proteinMarginal periodontitis and cytokines: a review of the literature.Reed-Sternberg cells and the TNF family of receptors/ligands.Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.Tumour necrosis factor and Crohn's diseaseImpaired TNF-alpha control of IP3R-mediated Ca2+ release in Alzheimer's disease mouse neurons.A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis.Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainageImmunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer.Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators.Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.
P2860
Q24295266-3A147216-B796-4F58-AAA5-97A9EEC83AB1Q27347256-B89D166B-D33F-4AC2-A820-953CEA30C6B3Q28115550-53C16A9F-6F4C-4060-A996-81E9FC2668D1Q28248843-E85F9D0E-1DFE-4A67-A772-6C8220454416Q33204535-15701A39-7489-42FE-9A9D-6A3517AB4850Q33618298-AA0346E1-AB9F-44AA-BBBC-8DB509616F7AQ33641577-8FF6A9B8-1AD4-48DC-9A86-608811E7C81FQ33937394-94189AE0-B21D-4259-8CE3-746F01C5788FQ33937497-227106A9-39D1-441F-B224-B6A7FA4FB687Q34071248-9AB3690E-5CF8-4EFD-A629-0CDE5D1FF22AQ34454342-8E22AD59-AD45-42CB-889B-5D5310130467Q34788072-191C6D0D-C847-47DC-B6AD-5233D4B1BDE3Q35224862-15162E20-EBE5-43D6-A821-1334098137E0Q35780800-DAC405F3-2C03-433D-87C0-076118D69989Q36135454-6857575F-C2FB-42D3-9079-79AAE234F7E6Q36361402-F87C8AEF-9375-4525-A570-6F401113B665Q36365272-8660A0CB-45B6-459B-9568-EDA34976A0B2Q36935627-609CCF97-5491-4389-9A6E-09288F3A9DA9Q37120079-AE0E5393-8B68-4C2B-B4C9-B6FF16565C7BQ37696010-C53A645D-2E03-4D24-B6A4-86A07696320FQ40115290-5592FDAA-1D98-4A9B-88A7-5A4BEBB8EA05Q40305824-82BDC1D2-9D22-47D3-804A-DEE611D1B8ABQ40343302-5150C084-C849-4BEE-847E-7B69EC1D47B6Q40528753-EDDDD959-04AF-4F47-B338-A485FC715EF5Q40548687-304C3C95-19F0-45AC-9536-8F9F9C51AFEBQ40668708-D9AD4D24-3E81-406F-9DAC-5CE46D2C9A5AQ40790725-E1914B62-F8FA-4632-A44D-1ED3ED854C3CQ40808203-BD53299A-BBFB-4668-9BF9-C9788CF1F426Q40875592-309E5B0C-2EA8-4F49-831C-6E078060B0F4Q41020476-FA306F14-801D-44D9-B6D2-1B4DC831D7B3Q41068693-7D7ECD99-7CE9-4503-A7AE-FCF5F591BEE3Q41163144-5C0C831A-39A5-465F-9242-E5C07B7D49DCQ41491900-BC7CA4E8-BD5E-4B5D-883C-122FBF40A497Q41869581-1E6927A3-4133-4C1F-9286-668A490391AEQ42092652-23B30F5D-5D87-41CD-B641-F7EE2E251C19Q42121332-ADDC97A3-5E8B-4744-8207-062A391A10B1Q43922180-8F35F8F1-27AE-4155-AD27-B721F040B516Q44549620-20F044C1-3D87-42A1-904D-8D2A9097DE08Q44696092-3F4FB533-B04A-4481-A4D8-56DAED3009E6Q45112568-7774C8EE-253E-459B-B84C-156B7AB55A84
P2860
Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Characterization in vitro of a ...... umor necrosis factor receptor.
@en
type
label
Characterization in vitro of a ...... umor necrosis factor receptor.
@en
prefLabel
Characterization in vitro of a ...... umor necrosis factor receptor.
@en
P2093
P2860
P356
P1476
Characterization in vitro of a ...... umor necrosis factor receptor.
@en
P2093
P2860
P304
P356
10.1172/JCI114853
P407
P577
1990-11-01T00:00:00Z